(Last updated: May 1, 2014; last reviewed: April 8, 2015)
|Generic Name (Abbreviation)/ Trade Name||Formulation||
|150 and 300 mg tablets||150 mg BID when given with drugs that are strong CYP3A inhibitors (with or without CYP3A inducers) including PIs (except TPV/r)
300 mg BID when given with NRTIs, T20, TPV/r, NVP, RAL, and other drugs that are not strong CYP3A inhibitors or inducers
600 mg BID when given with drugs that are CYP3A inducers, including EFV, ETR, etc. (without a CYP3A inhibitor)
Take without regard to meals.
|14-18 hours||CYP3A4 substrate||